Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Bibliographic Details
Main Authors: Kevin A. Lidberg, Andrew J. Annalora, Marija Jozic, Daniel J. Elson, Lu Wang, Theo K. Bammler, Susanne Ramm, Maria Beatriz Monteiro, Jonathan Himmelfarb, Craig B. Marcus, Patrick L. Iversen, Edward J. Kelly
Format: Article
Language:English
Published: Nature Publishing Group 2021-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-90075-z
id doaj-ffc507cf83ba4185b5e5704e026f577d
record_format Article
spelling doaj-ffc507cf83ba4185b5e5704e026f577d2021-05-23T11:33:37ZengNature Publishing GroupScientific Reports2045-23222021-05-011111110.1038/s41598-021-90075-zAuthor Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal diseaseKevin A. Lidberg0Andrew J. Annalora1Marija Jozic2Daniel J. Elson3Lu Wang4Theo K. Bammler5Susanne Ramm6Maria Beatriz Monteiro7Jonathan Himmelfarb8Craig B. Marcus9Patrick L. Iversen10Edward J. Kelly11Department of Pharmaceutics, University of WashingtonDepartment of Environmental and Molecular Toxicology, Oregon State UniversityDepartment of Environmental and Molecular Toxicology, Oregon State UniversityDepartment of Environmental and Molecular Toxicology, Oregon State UniversityDepartment of Environmental and Occupational Health Sciences, University of WashingtonDepartment of Environmental and Occupational Health Sciences, University of WashingtonVictorian Centre for Functional Genomics, Peter MacCallum Cancer CentreDepto Clinica Medica, Faculdade de Medicina FMUSP, Universidade de Sao PauloKidney Research Institute, University of WashingtonDepartment of Environmental and Molecular Toxicology, Oregon State UniversityDepartment of Environmental and Molecular Toxicology, Oregon State UniversityDepartment of Pharmaceutics, University of WashingtonAn amendment to this paper has been published and can be accessed via a link at the top of the paper.https://doi.org/10.1038/s41598-021-90075-z
collection DOAJ
language English
format Article
sources DOAJ
author Kevin A. Lidberg
Andrew J. Annalora
Marija Jozic
Daniel J. Elson
Lu Wang
Theo K. Bammler
Susanne Ramm
Maria Beatriz Monteiro
Jonathan Himmelfarb
Craig B. Marcus
Patrick L. Iversen
Edward J. Kelly
spellingShingle Kevin A. Lidberg
Andrew J. Annalora
Marija Jozic
Daniel J. Elson
Lu Wang
Theo K. Bammler
Susanne Ramm
Maria Beatriz Monteiro
Jonathan Himmelfarb
Craig B. Marcus
Patrick L. Iversen
Edward J. Kelly
Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
Scientific Reports
author_facet Kevin A. Lidberg
Andrew J. Annalora
Marija Jozic
Daniel J. Elson
Lu Wang
Theo K. Bammler
Susanne Ramm
Maria Beatriz Monteiro
Jonathan Himmelfarb
Craig B. Marcus
Patrick L. Iversen
Edward J. Kelly
author_sort Kevin A. Lidberg
title Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
title_short Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
title_full Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
title_fullStr Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
title_full_unstemmed Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
title_sort author correction: antisense oligonucleotide development for the selective modulation of cyp3a5 in renal disease
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-05-01
description An amendment to this paper has been published and can be accessed via a link at the top of the paper.
url https://doi.org/10.1038/s41598-021-90075-z
work_keys_str_mv AT kevinalidberg authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT andrewjannalora authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT marijajozic authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT danieljelson authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT luwang authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT theokbammler authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT susanneramm authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT mariabeatrizmonteiro authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT jonathanhimmelfarb authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT craigbmarcus authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT patrickliversen authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
AT edwardjkelly authorcorrectionantisenseoligonucleotidedevelopmentfortheselectivemodulationofcyp3a5inrenaldisease
_version_ 1721429646670561280